Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. - Wikidata - wikimedia - TriplyDB

Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates.

Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates.

http://www.wikidata.org/entity/Q37029301

about

Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine A 20-kilodalton N-terminal fragment of the D15 protein contains a protective epitope(s) against Haemophilus influenzae type a and type b.Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate.Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines.Phase I clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b in human adult volunteers.Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines.Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers.Haemophilus influenzae meningitis in Sweden 1981-1983.Pneumococcal resistance to antibiotics.Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate Contribution of a 28-kilodalton membrane protein to the virulence of Haemophilus influenzae.Distribution of protein D, an immunoglobulin D-binding protein, in Haemophilus strains.Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide.Immunogenicity of Streptococcus pneumoniae type 14 capsular polysaccharide: influence of carriers and adjuvants on isotype distribution.Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine.Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine.Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines.Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid Antibody-secreting peripheral blood lymphocytes induced by immunization with a conjugate consisting of Streptococcus pneumoniae type 12F polysaccharide and diphtheria toxoid.Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines Synthesis and physicochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates.Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.New vaccines for the prevention of pneumococcal infections.Comparison between radioimmunoassay and direct and indirect enzyme-linked immunosorbent assays for determination of antibodies against Haemophilus influenzae type b capsular polysaccharide.Serum antibody response to capsular polysaccharide, outer membrane, and lipooligosaccharide in children with invasive Haemophilus influenzae type b infections Maternal immunity and antibody response of neonatal mice to pneumococcal type 19F polysaccharide.Reengineering translational science: the time is right.Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children Protein D, the immunoglobulin D-binding protein of Haemophilus influenzae, is a lipoprotein Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum circumsporozoites.Limited diversity of the protein D gene (hpd) among encapsulated and nonencapsulated Haemophilus influenzae strains.The pneumococcus: host-organism interactions and their implications for immunotherapy and immunoprophylaxis.

P2860

Q33755319-A270901D-DB97-4C43-972D-26A72D694CC1 Q33756634-C9F1B594-5027-4F27-86A2-C8D18A950EDA Q34002272-ED315073-3C73-48BD-A473-B676697A2B05 Q34170021-AB4F8730-2A68-4C64-B878-496D3C2F149A Q34526987-9ABDA437-B954-4D6C-BA2A-EFD3FBA3E29C Q34529116-F61BDD95-6953-4286-8A51-56DE05DD3FF7 Q34541176-B59F195F-ADA8-4AF6-94D2-F91AA93667B1 Q35023397-481D9AC5-81B5-4BDA-A2EE-036887714F64 Q35093842-3E78DC90-DFF2-4A75-8195-3BE8DDED3003 Q35231638-51965E0A-8EAE-4EF5-9717-70C350FB81F0 Q35523144-B06B9DF2-D6C4-4D1F-9353-DFBB4DF0167B Q35604203-6CB7D8E6-A898-43C2-8D46-DB9E31264C2E Q36636190-C1515056-80F4-433C-9E12-4FC4EEB5DAC4 Q36958120-A6B465ED-E6F7-4775-9BEC-8293CAB23D76 Q36961608-623F69AC-11B7-46BA-B7DE-1CAED2FA1297 Q36961962-28DFC24D-273F-42D2-B818-8EADDF922DEE Q36966367-8235DF62-CD5B-41BF-A1A2-7A76ADA372D6 Q36967322-AB9F077F-CF4B-4BC4-BAAD-31EC2F840DC1 Q36970577-0B3738DC-3E5C-436E-9BA8-33EBCE554909 Q36974733-ADA5FB94-A3A3-4326-9ED6-74C54635D00D Q36976544-E90B090F-A61E-4D06-9386-4EEA3822C04A Q36978212-42689880-ECBD-451B-8B0F-7EFA9BFA9F1E Q36985836-D21C7C66-2AEA-415F-98B9-2E2A1E31E9D5 Q36986779-A0357950-A94C-49DE-8A73-15427B0762D3 Q36987808-8D5E4562-2FC1-4D52-A377-0718C0EFC6BB Q36998805-AE181985-A8DA-4FC0-A6A2-AE53EBA3BE9F Q37058833-440ABD7E-77CD-4E4E-85E0-1D5674721929 Q37091903-38B6B444-A7A0-47D9-B65B-2F83BB95E96C Q37159267-CDF003E8-9183-426E-87D1-B709EE0989FF Q37223650-920C4E4E-85B7-40A9-85DE-DDAF7DC1192F Q37242492-E198DCEE-5660-4C77-9C03-5B57B7AC73D1 Q37403328-99113420-5D0F-4619-AF97-F7C95D9C4CB8 Q37582928-A9240E71-7565-42D6-BF2B-83F7ACF32B39 Q38329645-A5474CCD-D400-49CC-84CC-E3711E8121E5 Q40159003-25256F01-F98E-47FA-A5B5-F39AF9D83D53 Q40269306-F8DA522A-1D09-4688-9522-14CA33496084 Q42415387-29D61CF7-F958-4645-9675-3F00AED994C2

P2860

Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates.

http://www.wikidata.org/entity/Q37029301

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 1986

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Quantitative and qualitative a ...... ide-tetanus toxoid conjugates.

@en

Quantitative and qualitative a ...... ide-tetanus toxoid conjugates.

@nl

type

label

Quantitative and qualitative a ...... ide-tetanus toxoid conjugates.

@en

Quantitative and qualitative a ...... ide-tetanus toxoid conjugates.

@nl

prefLabel

Quantitative and qualitative a ...... ide-tetanus toxoid conjugates.

@en

Quantitative and qualitative a ...... ide-tetanus toxoid conjugates.

@nl

P1433

Q37029301-91892E7F-D0B7-432C-9FF8-1C75D5D01B42

P1476

Q37029301-F70F64DB-2305-4413-9756-A41759AFF3F7

P2093

Q37029301-156B8DA7-9132-443A-AEE1-4487A4DED43D

Q37029301-16B7086A-0B2D-4415-A438-F0BA9DE8F16E

Q37029301-1ABDD528-63CB-4E80-BECA-39A27FE36A95

Q37029301-3AE072C6-6FAC-4645-8D6C-2AEE28972937

Q37029301-5B550E15-2D49-4EAA-B951-A7ED61E8DB9C

Q37029301-5EDA3FEC-6A3C-410D-9538-8BDBBB731056

Q37029301-898970AD-85C8-4BAF-B604-0E11909C7049

Q37029301-8FD1E12E-4117-490D-BF45-03CFCCA01E56

Q37029301-990A8F68-73BE-4FFA-BF67-76C58B9D907D

Q37029301-BE5602FB-9DAA-48FE-87EF-21C166992A59

P2860

Q37029301-059F9606-5900-46CE-9BC1-6A5834092619

Q37029301-07487A22-7A2C-4F0A-B5B8-7B45C8B9CA44

Q37029301-0F90372E-31A4-49F6-B409-174623BCDA31

Q37029301-0F9D8697-27EE-4C26-8214-3102F1B68411

Q37029301-11FC578D-3491-4195-86CB-BBB1ACEB3D75

Q37029301-16DDEA0F-92E2-4F6C-84D1-78E3996A9A33

Q37029301-22039B0D-3D94-4BE2-9129-0E466EA5B4CE

Q37029301-2AE7D1AB-18EC-4154-985F-1F7373507291

Q37029301-2E83F9CD-1EB3-493C-B2A6-11308DD96A2F

Q37029301-34E133F5-2542-42D5-8518-2401C34AFB80

P304

Q37029301-B6BFC42D-A329-43B9-9CD6-6BC5FB600034

P31

Q37029301-DCCF8C26-61D1-40E6-86A9-6227F9F9B02A

P407

Q37029301-D686F145-1232-45DA-92B3-1EF0AD27FF3A

P433

Q37029301-FE9EE135-859A-45E6-8836-9BD5AB25BEDE

P478

Q37029301-A643A8F2-A03F-4B9B-BA68-2432DB18C6CF

P577

Q37029301-A2999A63-8344-4B4D-AEBB-C58CFD1C7A91

P698

Q37029301-847F4C39-6BE6-4E7F-B0F9-68E8286D46BC

P921

Q37029301-0237D53F-63A0-4C55-9022-E493FF1AD270

Q37029301-ECAC750E-E7A4-4231-BF60-A1CF19AE4C25

P932

Q37029301-4EF92851-F2FE-478C-8930-22CCCC8B5F54

P1433

Infection and Immunity

P1476

Quantitative and qualitative a ...... ide-tetanus toxoid conjugates.

@en

P2093

Bell C

http://www.w3.org/2001/XMLSchema#string

Karpas A

http://www.w3.org/2001/XMLSchema#string

Parke JC Jr

http://www.w3.org/2001/XMLSchema#string

Robbins JB

http://www.w3.org/2001/XMLSchema#string

Schiffman G

http://www.w3.org/2001/XMLSchema#string

Schlesselman JJ

http://www.w3.org/2001/XMLSchema#string

Schneerson R

http://www.w3.org/2001/XMLSchema#string

Shiloach J

http://www.w3.org/2001/XMLSchema#string

Sutton A

http://www.w3.org/2001/XMLSchema#string

Wang Z

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody response to successive booster doses of tetanus toxoid in adults

Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis

Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197.

Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.

Human immunity to the meningococcus. I. The role of humoral antibodies.

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.

Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates

Immunization against neonatal tetanus in New Guinea. 3. The toxin-neutralization test and the response of guinea-pigs to the toxoids as used in the immunization schedules in New Guinea.

Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.

P304

519-528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

1986-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3516876

http://www.w3.org/2001/XMLSchema#string

P921

polysaccharides

P932

261031

http://www.w3.org/2001/XMLSchema#string